Compass Minerals International (CMP) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Jul, 2026Executive summary
Revenue rose 36% year-over-year to $494.6M, driven by higher Salt and Plant Nutrition volumes, though offset by lower average sales prices.
Net loss for Q2 FY2025 was $32.0M, an improvement from $38.9M in the prior year; adjusted EBITDA was $84.1M, down from $95.7M, impacted by lower contingent consideration gains.
Significant progress on cost optimization and inventory reduction, including a $150M working capital release and an 18% net debt reduction in the quarter.
Over 10% of the corporate workforce was eliminated and Fortress North America business is being wound down, resulting in a $53.0M impairment charge.
Adjusted net earnings for Q2 FY2025 were $25.7M, or $0.63 per diluted share, compared to $74.2M, or $1.78 per share, in Q2 FY2024.
Financial highlights
Q2 revenue was $494.6M, up 36% year-over-year; adjusted EBITDA margin was 17.0%.
Gross profit increased 7% to $76.8M, but gross margin declined to 16% from 20% year-over-year.
Operating loss improved to $3.1M from $39.3M last year; net loss margin for the quarter was (6.5%).
Liquidity at quarter end was $328.6M, including $49.5M cash and $279.1M available under the revolving credit facility.
Cash from operations for six months was $182.8M, up from $33.9M year-over-year.
Outlook and guidance
FY2025 Salt segment sales volumes expected at 10.45–10.9M tons; revenue $975–$1,050M; adjusted EBITDA $215–$230M.
Plant Nutrition FY2025 sales volumes expected at 295–315K tons; revenue $180–$200M; adjusted EBITDA $17–$24M.
Total company adjusted EBITDA guidance: $173–$202M; capital expenditures projected at $75–$85M; effective tax rate expected at 13–18%.
Interest expense forecasted at $67–$72M.
Market conditions for the upcoming bid season are constructive, with potential for stronger pricing and higher volume commitments.
Latest events from Compass Minerals International
- Q2 2026 delivered higher margins, reduced debt, and strong Plant Nutrition growth.CMP
Q2 202629 Jun 2026 - All voting items passed and no stockholder questions were raised during the meeting.CMP
AGM 20266 Mar 2026 - Q1 2026 net income hit $18.6M, EBITDA doubled, and guidance was raised on strong salt results.CMP
Q1 20266 Feb 2026 - Shareholders will vote on directors, executive pay, and auditor, with a focus on governance and ESG.CMP
Proxy Filing23 Jan 2026 - Key votes include director elections, executive pay, and auditor ratification for 2026.CMP
Proxy Filing23 Jan 2026 - 2024 net loss from impairments; 2025 outlook sees Salt volume growth and stable capex.CMP
Q4 202411 Jan 2026 - Q1 FY2025 revenue down 10%, net loss narrowed, and Plant Nutrition volumes rose.CMP
Q1 202516 Dec 2025 - Net loss narrowed, debt fell, and 2026 guidance targets margin and EBITDA growth.CMP
Q4 20259 Dec 2025 - Proxy covers director elections, executive pay, incentive plan amendment, auditor ratification, and ESG goals.CMP
Proxy Filing1 Dec 2025